BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8811200)

  • 1. Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method.
    Kodama E; Shigeta S; Suzuki T; De Clercq E
    Antiviral Res; 1996 Jul; 31(3):159-64. PubMed ID: 8811200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
    Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of antiviral agents for adenovirus using the MTT method in vitro].
    Kaneko H; Fujiwara T; Mori S; Shigeta S
    Nippon Ganka Gakkai Zasshi; 2000 Nov; 104(11):786-91. PubMed ID: 11530368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2'-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro.
    Gordon YJ; Romanowski E; Araullo-Cruz T; Seaberg L; Erzurum S; Tolman R; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):11-6. PubMed ID: 1776874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro.
    Shigeta S; Konno K; Baba M; Yokota T; De Clercq E
    J Infect Dis; 1991 Feb; 163(2):270-5. PubMed ID: 1846389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro.
    Snoeck R; Lagneaux L; Delforge A; Bron D; Van der Auwera P; Stryckmans P; Balzarini J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):615-9. PubMed ID: 2170136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
    Neyts J; Snoeck R; Balzarini J; De Clercq E
    Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
    Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
    Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibitory effect of (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 2'-nor-cyclic GMP on adenovirus replication in vitro.
    Baba M; Mori S; Shigeta S; De Clercq E
    Antimicrob Agents Chemother; 1987 Feb; 31(2):337-9. PubMed ID: 3566256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
    Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
    J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
    Kaneko H; Mori S; Suzuki O; Iida T; Shigeta S; Abe M; Ohno S; Aoki K; Suzutani T
    Antiviral Res; 2004 Jan; 61(1):63-6. PubMed ID: 14670595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication.
    Snoeck R; Sakuma T; De Clercq E; Rosenberg I; Holy A
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1839-44. PubMed ID: 2854454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiviral effect of sulfated sialyl lipid against a clinical strain of adenovirus].
    Kaneko H; Mori S; Shigeta S; Ohno S; Aoki K
    Nippon Ganka Gakkai Zasshi; 2003 Apr; 107(4):196-201. PubMed ID: 12755063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
    Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiviral effect of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine on adenovirus].
    Nakajima H; Goto M; Shimada Y; Nagamoto Y; Ishiko H; Inagawa W; Itoh N; Uchio E; Ohno S; Aoki K
    Nippon Ganka Gakkai Zasshi; 2000 Feb; 104(2):77-81. PubMed ID: 10714154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir.
    Gordon YJ; Araullo-Cruz TP; Johnson YF; Romanowski EG; Kinchington PR
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2774-8. PubMed ID: 8977495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors.
    Bedard J; May S; Barbeau D; Yuen L; Rando RF; Bowlin TL
    Antiviral Res; 1999 Feb; 41(1):35-43. PubMed ID: 10321577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of various compounds against clinical strains of herpes simplex virus.
    Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.